{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:15:54Z","timestamp":1791278154944,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"DOI":"10.1093\/brain\/awh625","type":"journal-article","created":{"date-parts":[[2005,10,12]],"date-time":"2005-10-12T03:13:20Z","timestamp":1129086800000},"page":"2665-2674","source":"Crossref","is-referenced-by-count":323,"title":["A possible role for humoral immunity in the pathogenesis of Parkinson's disease"],"prefix":"10.1093","volume":"128","author":[{"given":"Carolyn F.","family":"Orr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic B.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikuni","family":"Mizuno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideo","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"Halliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,10,11]]},"reference":[{"key":"key\n\t\t\t\t20171011164532_B1","doi-asserted-by":"crossref","unstructured":"Aloisi F. Immune function of microglia. Glia2001; 36: 165\u201379.","DOI":"10.1002\/glia.1106"},{"key":"key\n\t\t\t\t20171011164532_B2","doi-asserted-by":"crossref","unstructured":"Appel SH, Le WD, Tajti J, Haverkamp LJ, Engelhardt JI. Nigral damage and dopaminergic hypofunction in mesencephalon-immunized guinea pigs. Ann Neurol1992; 32: 494\u2013501.","DOI":"10.1002\/ana.410320403"},{"key":"key\n\t\t\t\t20171011164532_B3","doi-asserted-by":"crossref","unstructured":"Banati RB, Daniel SE, Blunt SB. Glial pathology but absence of apoptotic nigral neurons in long-standing Parkinson's disease. Mov Disord1998; 13: 221\u20137.","DOI":"10.1002\/mds.870130205"},{"key":"key\n\t\t\t\t20171011164532_B4","doi-asserted-by":"crossref","unstructured":"Benner EJ, Mosley RL, Destache CJ, Lewis TB, Jackson-Lewis V, Gorantla S, et al. Therapeutic immunization protects dopaminergic neurons in a mouse model of Parkinson's disease. Proc Natl Acad Sci USA2004; 101: 9435\u201340.","DOI":"10.1073\/pnas.0400569101"},{"key":"key\n\t\t\t\t20171011164532_B5","doi-asserted-by":"crossref","unstructured":"Boren E, Gershwin ME. Inflamm-aging: autoimmunity, and the immune-risk phenotype. Autoimmun Rev2004; 3: 401\u20136.","DOI":"10.1016\/j.autrev.2004.03.004"},{"key":"key\n\t\t\t\t20171011164532_B6","doi-asserted-by":"crossref","unstructured":"Boska MD, Lewis TB, Destache CJ, Benner EJ, Nelson JA, Uberti M, et al. Quantitative 1H magnetic resonance spectroscopic imaging determines therapeutic immunization efficacy in an animal model of Parkinson's disease. J Neurosci2005; 25: 1691\u2013700.","DOI":"10.1523\/JNEUROSCI.4364-04.2005"},{"key":"key\n\t\t\t\t20171011164532_B7","doi-asserted-by":"crossref","unstructured":"Chen H, Zhang SM, Hernan MA, Schwarzschild MA, Willett WC, Colditz GA, et al. Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. Arch Neurol2003; 60: 1059\u201364.","DOI":"10.1001\/archneur.60.8.1059"},{"key":"key\n\t\t\t\t20171011164532_B8","doi-asserted-by":"crossref","unstructured":"Clarke G, Collins RA, Leavitt BR, Andrews DF, Hayden MR, Lumsden CJ, et al. A one-hit model of cell death in inherited neuronal degenerations. Nature2000; 406: 195\u20139.","DOI":"10.1038\/35018098"},{"key":"key\n\t\t\t\t20171011164532_B9","doi-asserted-by":"crossref","unstructured":"D'Andrea MR. Add Alzheimer's disease to the list of autoimmune diseases. Med Hypotheses2005; 64: 458\u201363.","DOI":"10.1016\/j.mehy.2004.08.024"},{"key":"key\n\t\t\t\t20171011164532_B10","doi-asserted-by":"crossref","unstructured":"Defazio G, Dal Toso R, Benvegnu D, Minozzi MC, Cananzi AR, Leon A. Parkinsonian serum carries complement-dependent toxicity for rat mesencephalic dopaminergic neurons in culture. Brain Res1994; 633: 206\u201312.","DOI":"10.1016\/0006-8993(94)91541-5"},{"key":"key\n\t\t\t\t20171011164532_B11","doi-asserted-by":"crossref","unstructured":"Fearnley JM, Lees AJ. Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain1991; 114: 2283\u2013301.","DOI":"10.1093\/brain\/114.5.2283"},{"key":"key\n\t\t\t\t20171011164532_B12","doi-asserted-by":"crossref","unstructured":"Flugel A, Bradl M, Kreutzberg GW, Graeber MB. Transformation of donor-derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy. J Neurosci Res2001; 66: 74\u201382.","DOI":"10.1002\/jnr.1198"},{"key":"key\n\t\t\t\t20171011164532_B13","doi-asserted-by":"crossref","unstructured":"Gao HM, Hong JS, Zhang W, Liu B. Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons. J Neurosci2002; 22: 782\u201390.","DOI":"10.1523\/JNEUROSCI.22-03-00782.2002"},{"key":"key\n\t\t\t\t20171011164532_B14","doi-asserted-by":"crossref","unstructured":"Gao HM, Jiang J, Wilson B, Zhang W, Hong JS, Liu B. Microglial activation-mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease. J Neurochem2002; 81: 1285\u201397.","DOI":"10.1046\/j.1471-4159.2002.00928.x"},{"key":"key\n\t\t\t\t20171011164532_B15","doi-asserted-by":"crossref","unstructured":"Gelb DJ, Oliver E, Gilman S. Diagnostic criteria for Parkinson disease. Arch Neurol1999; 56: 33\u20139.","DOI":"10.1001\/archneur.56.1.33"},{"key":"key\n\t\t\t\t20171011164532_B16","doi-asserted-by":"crossref","unstructured":"Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, Corsi MP, et al. The immune system in the elderly: I. Specific humoral immunity. Immunol Res1999; 20: 101\u20138.","DOI":"10.1007\/BF02786466"},{"key":"key\n\t\t\t\t20171011164532_B17","doi-asserted-by":"crossref","unstructured":"Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, Martorelli V, et al. The immune system in the elderly: II. Specific cellular immunity. Immunol Res1999; 20: 109\u201315.","DOI":"10.1007\/BF02786467"},{"key":"key\n\t\t\t\t20171011164532_B18","doi-asserted-by":"crossref","unstructured":"Ginaldi L, De Martinis M, D'Ostilio A, Marini L, Loreto MF, Quaglino D. The immune system in the elderly: III. Innate immunity. Immunol Res1999; 20: 117\u201326.","DOI":"10.1007\/BF02786468"},{"key":"key\n\t\t\t\t20171011164532_B19","doi-asserted-by":"crossref","unstructured":"Halliday GM, McRitchie DA, Cartwright H, Pamphlett R, Hely MA, Morris JGL. Midbrain neuropathology in idiopathic Parkinson's disease and diffuse Lewy body disease. J Clin Neurosci1996; 3: 52\u201360.","DOI":"10.1016\/S0967-5868(96)90083-1"},{"key":"key\n\t\t\t\t20171011164532_B20","doi-asserted-by":"crossref","unstructured":"Haussermann P, Kuhn W, Przuntek H, Muller T. Integrity of the blood-cerebrospinal fluid barrier in early Parkinson's disease. Neurosci Lett2001; 300: 182\u20134.","DOI":"10.1016\/S0304-3940(01)01574-9"},{"key":"key\n\t\t\t\t20171011164532_B21","doi-asserted-by":"crossref","unstructured":"He Y, Appel S, Le W. Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum. Brain Res2001; 909: 187\u201393.","DOI":"10.1016\/S0006-8993(01)02681-6"},{"key":"key\n\t\t\t\t20171011164532_B22","doi-asserted-by":"crossref","unstructured":"He Y, Le WD, Appel SH. Role of Fcgamma receptors in nigral cell injury induced by Parkinson disease immunoglobulin injection into mouse substantia nigra. Exp Neurol2002; 176: 322\u20137.","DOI":"10.1006\/exnr.2002.7946"},{"key":"key\n\t\t\t\t20171011164532_B23","doi-asserted-by":"crossref","unstructured":"Huang Y, Cheung L, Rowe D, Halliday G. Genetic contributions to Parkinson's disease. Brain Res Brain Res Rev2004; 46: 44\u201370.","DOI":"10.1016\/j.brainresrev.2004.04.007"},{"key":"key\n\t\t\t\t20171011164532_B24","doi-asserted-by":"crossref","unstructured":"Hughes BW, Moro De Casillas ML, Kaminski HJ. Pathophysiology of myasthenia gravis. Semin Neurol2004; 24: 21\u201330.","DOI":"10.1055\/s-2004-829585"},{"key":"key\n\t\t\t\t20171011164532_B25","doi-asserted-by":"crossref","unstructured":"Hunot S, Hirsch EC. Neuroinflammatory processes in Parkinson's disease. Ann Neurol2003; 53 (Suppl. 3): S49\u2013S5, discussion S58\u2013S60.","DOI":"10.1002\/ana.10481"},{"key":"key\n\t\t\t\t20171011164532_B26","doi-asserted-by":"crossref","unstructured":"Imamura K, Hishikawa N, Sawada M, Nagatsu T, Yoshida M, Hashizume Y. Distribution of major histocompatibility complex class II-positive microglia and cytokine profile of Parkinson's disease brains. Acta Neuropathol (Berl)2003; 106: 518\u201326.","DOI":"10.1007\/s00401-003-0766-2"},{"key":"key\n\t\t\t\t20171011164532_B27","doi-asserted-by":"crossref","unstructured":"Jernigan M, Morcos Y, Lee SM, Dohan FC Jr, Raine C, Levin MC. IgG in brain correlates with clinicopathological damage in HTLV-1 associated neurologic disease. Neurology2003; 60: 1320\u20137.","DOI":"10.1212\/01.WNL.0000059866.03880.BA"},{"key":"key\n\t\t\t\t20171011164532_B28","doi-asserted-by":"crossref","unstructured":"Kalume F, Lee SM, Morcos Y, Callaway JC, Levin MC. Molecular mimicry: cross-reactive antibodies from patients with immune-mediated neurologic disease inhibit neuronal firing. J Neurosci Res2004; 77: 82\u20139.","DOI":"10.1002\/jnr.20137"},{"key":"key\n\t\t\t\t20171011164532_B29","doi-asserted-by":"crossref","unstructured":"Kim WG, Mohney RP, Wilson B, Jeohn GH, Liu B, Hong JS. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J Neurosci2000; 20: 6309\u201316.","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000"},{"key":"key\n\t\t\t\t20171011164532_B30","doi-asserted-by":"crossref","unstructured":"Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, et al. Blood-brain barrier dysfunction in parkinsonian midbrain in vivo. Ann Neurol2005; 57: 176\u20139.","DOI":"10.1002\/ana.20369"},{"key":"key\n\t\t\t\t20171011164532_B31","doi-asserted-by":"crossref","unstructured":"Kreutzberg GW. Microglia: a sensor for pathological events in the CNS. Trends Neurosci1996; 19: 312\u20138.","DOI":"10.1016\/0166-2236(96)10049-7"},{"key":"key\n\t\t\t\t20171011164532_B32","doi-asserted-by":"crossref","unstructured":"Kurkowska-Jastrzebska I, Wronska A, Kohutnicka M, Czlonkowski A, Czlonkowska A. MHC class II positive microglia and lymphocytic infiltration are present in the substantia nigra and striatum in mouse model of Parkinson's disease. Acta Neurobiol Exp (Warsz)1999; 59: 1\u20138.","DOI":"10.55782\/ane-1999-1289"},{"key":"key\n\t\t\t\t20171011164532_B33","doi-asserted-by":"crossref","unstructured":"Le WD, Engelhardt J, Xie WJ, Schneider L, Smith RG, Appel SH. Experimental autoimmune nigral damage in guinea pigs. J Neuroimmunol1995; 57: 45\u201353.","DOI":"10.1016\/0165-5728(94)00160-P"},{"key":"key\n\t\t\t\t20171011164532_B34","doi-asserted-by":"crossref","unstructured":"Levin MC, Krichavsky M, Berk J, Foley S, Rosenfeld M, Dalmau J, et al. Neuronal molecular mimicry in immune-mediated neurologic disease. Ann Neurol1998; 44: 87\u201398.","DOI":"10.1002\/ana.410440115"},{"key":"key\n\t\t\t\t20171011164532_B35","doi-asserted-by":"crossref","unstructured":"Levin MC, Lee SM, Kalume F, Morcos Y, Dohan FC Jr, Hasty KA, et al. Autoimmunity due to molecular mimicry as a cause of neurological disease. Nat Med2002; 8: 509\u201313.","DOI":"10.1038\/nm0502-509"},{"key":"key\n\t\t\t\t20171011164532_B36","doi-asserted-by":"crossref","unstructured":"Lindersson E, Lundvig D, Petersen C, Madsen P, Nyengaard JR, Hojrup P, et al. p25alpha stimulates alpha-synuclein aggregation and is co-localized with aggregated alpha-synuclein in alpha-synucleinopathies. J Biol Chem2005; 280: 5703\u201315.","DOI":"10.1074\/jbc.M410409200"},{"key":"key\n\t\t\t\t20171011164532_B37","doi-asserted-by":"crossref","unstructured":"Liu B, Du L, Hong JS. Naloxone protects rat dopaminergic neurons against inflammatory damage through inhibition of microglia activation and superoxide generation. J Pharmacol Exp Ther2000; 293: 607\u201317.","DOI":"10.1016\/S0022-3565(24)39275-4"},{"key":"key\n\t\t\t\t20171011164532_B38","doi-asserted-by":"crossref","unstructured":"McGeer PL, Itagaki S, Boyes BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology1988; 38: 1285\u201391.","DOI":"10.1212\/WNL.38.8.1285"},{"key":"key\n\t\t\t\t20171011164532_B39","doi-asserted-by":"crossref","unstructured":"Mirza B, Hadberg H, Thomsen P, Moos T. The absence of reactive astrocytosis is indicative of a unique inflammatory process in Parkinson's disease. Neuroscience2000; 95: 425\u201332.","DOI":"10.1016\/S0306-4522(99)00455-8"},{"key":"key\n\t\t\t\t20171011164532_B40","doi-asserted-by":"crossref","unstructured":"Mizuno Y, Hattori N, Mori H, Suzuki T, Tanaka K. Parkin and Parkinson's disease. Curr Opin Neurol2001; 14: 477\u201382.","DOI":"10.1097\/00019052-200108000-00008"},{"key":"key\n\t\t\t\t20171011164532_B41","doi-asserted-by":"crossref","unstructured":"Orr CF, Rowe DB, Halliday GM. An inflammatory review of Parkinson's disease. Prog Neurobiol2002; 68: 325\u201340.","DOI":"10.1016\/S0301-0082(02)00127-2"},{"key":"key\n\t\t\t\t20171011164532_B42","doi-asserted-by":"crossref","unstructured":"Ouchi Y, Yoshikawa E, Sekine Y, Futatsubashi M, Kanno T, Ogusu T, et al. Microglial activation and dopamine terminal loss in early Parkinson's disease. Ann Neurol2005; 57: 168\u201375.","DOI":"10.1002\/ana.20338"},{"key":"key\n\t\t\t\t20171011164532_B43","doi-asserted-by":"crossref","unstructured":"Overmyer M, Helisalmi S, Soininen H, Laakso M, Riekkinen P Sr, Alafuzoff I. Reactive microglia in aging and dementia: an immunohistochemical study of postmortem human brain tissue. Acta Neuropathol (Berl)1999; 97: 383\u201392.","DOI":"10.1007\/s004010051002"},{"key":"key\n\t\t\t\t20171011164532_B44","unstructured":"Roitt I, Brostoff J, Male D. Immunology. Vol 1. London: Elsevier Science Ltd; 2001."},{"key":"key\n\t\t\t\t20171011164532_B45","doi-asserted-by":"crossref","unstructured":"Shepherd CE, Thiel E, McCann H, Harding AJ, Halliday GM. Cortical inflammation in Alzheimer disease but not dementia with Lewy bodies. Arch Neurol2000; 57: 817\u201322.","DOI":"10.1001\/archneur.57.6.817"},{"key":"key\n\t\t\t\t20171011164532_B46","doi-asserted-by":"crossref","unstructured":"Spira PJ, Sharpe DM, Halliday G, Cavanagh J, Nicholson GA. Clinical and pathological features of a Parkinsonian syndrome in a family with an Ala53Thr alpha-synuclein mutation. Ann Neurol2001; 49: 313\u20139.","DOI":"10.1002\/ana.67"},{"key":"key\n\t\t\t\t20171011164532_B47","doi-asserted-by":"crossref","unstructured":"Stein TD, Fedynyshyn JP, Kalil RE. Circulating autoantibodies recognize and bind dying neurons following injury to the brain. J Neuropathol Exp Neurol2002; 61: 1100\u20138.","DOI":"10.1093\/jnen\/61.12.1100"},{"key":"key\n\t\t\t\t20171011164532_B48","doi-asserted-by":"crossref","unstructured":"Ulvestad E, Williams K, Matre R, Nyland H, Olivier A, Antel J. Fc receptors for IgG on cultured human microglia mediate cytotoxicity and phagocytosis of antibody-coated targets. J Neuropathol Exp Neurol1994; 53: 27\u201336.","DOI":"10.1097\/00005072-199401000-00004"},{"key":"key\n\t\t\t\t20171011164532_B49","doi-asserted-by":"crossref","unstructured":"Wu DC, Jackson-Lewis V, Vila M, Tieu K, Teismann P, Vadseth C, et al. Blockade of microglial activation is neuroprotective in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson disease. J Neurosci2002; 22: 1763\u201371.","DOI":"10.1523\/JNEUROSCI.22-05-01763.2002"},{"key":"key\n\t\t\t\t20171011164532_B50","doi-asserted-by":"crossref","unstructured":"Yamada T, McGeer PL, McGeer EG. Lewy bodies in Parkinson's disease are recognized by antibodies to complement proteins. Acta Neuropathol (Berl)1992; 84: 100\u20134.","DOI":"10.1007\/BF00427222"}],"container-title":["Brain"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/brain\/article-pdf\/128\/11\/2665\/971619\/awh625.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T22:13:37Z","timestamp":1736028817000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/brain\/article\/128\/11\/2665\/339583\/A-possible-role-for-humoral-immunity-in-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,10,11]]},"references-count":50,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,10,11]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/brain\/awh625","relation":{},"ISSN":["1460-2156","0006-8950"],"issn-type":[{"value":"1460-2156","type":"electronic"},{"value":"0006-8950","type":"print"}],"subject":[],"published-other":{"date-parts":[[2005,11]]},"published":{"date-parts":[[2005,10,11]]}}}